COVASXCleo Diagnostics Ltd

COV price activity

Last Price

Change (24hr)

AUD (%)

Volume

Volume (4w avg)

Previous Close

N/A

Last Trade

COV price performance

-6,76%

-8,12%

-47,6%

YTD

-11,94%

COV price fundamentals

N/A

Shares Issued

N/A

Earnings Per Share (EPS)

N/A

Dividends Per Share (DPS)

N/A

P/E Ratio

Price market cap

Market cap

N/A

AU-ASX rank

N/A

Sector Rank

N/A

COV details

View company website

View AU-ASX Official Page

Dividendos de COV

Ver mais

quote.marketSignals

Mais formas de descobrir

Ver notícias de Australia Descubra sinais de ASX Ver todas as ações de ASX Ver todos os ETFs de ASX

Cleo Diagnostics Ltd (AU-ASX: COV)

Cleo Diagnostics Ltd, a biotechnology company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral. It also focuses on developing and testing intellectual property, testing the IP, and securing patents. Cleo Diagnostics Ltd was incorporated in 2021 and is based in Melbourne, Australia.

Price: A$0.32

Sector: Healthcare — Medical Devices